- Home
- ASGN vs SUPN Comparison
ASGN vs SUPN Comparison
Compare ASGN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- SUPN
- Stock Information
- Founded
- ASGN 1985
- SUPN 2005
- Country
- ASGN United States
- SUPN United States
- Employees
- ASGN N/A
- SUPN N/A
- Industry
- ASGN Professional Services
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- ASGN Consumer Discretionary
- SUPN Health Care
- Exchange
- ASGN Nasdaq
- SUPN Nasdaq
- Market Cap
- ASGN 2.3B
- SUPN 1.9B
- IPO Year
- ASGN 1992
- SUPN 2012
- Fundamental
- Price
- ASGN $48.58
- SUPN $32.28
- Analyst Decision
- ASGN Hold
- SUPN Hold
- Analyst Count
- ASGN 6
- SUPN 2
- Target Price
- ASGN $71.33
- SUPN $36.00
- AVG Volume (30 Days)
- ASGN 418.1K
- SUPN 529.3K
- Earning Date
- ASGN 07-23-2025
- SUPN 08-05-2025
- Dividend Yield
- ASGN N/A
- SUPN N/A
- EPS Growth
- ASGN N/A
- SUPN N/A
- EPS
- ASGN 3.52
- SUPN 1.11
- Revenue
- ASGN $4,019,000,000.00
- SUPN $667,997,000.00
- Revenue This Year
- ASGN N/A
- SUPN N/A
- Revenue Next Year
- ASGN $3.20
- SUPN $12.02
- P/E Ratio
- ASGN $13.80
- SUPN $29.32
- Revenue Growth
- ASGN N/A
- SUPN 11.82
- 52 Week Low
- ASGN $47.64
- SUPN $25.55
- 52 Week High
- ASGN $105.67
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- ASGN 31.58
- SUPN 48.28
- Support Level
- ASGN $50.53
- SUPN $31.56
- Resistance Level
- ASGN $55.86
- SUPN $33.15
- Average True Range (ATR)
- ASGN 1.37
- SUPN 0.92
- MACD
- ASGN -0.34
- SUPN -0.03
- Stochastic Oscillator
- ASGN 2.08
- SUPN 40.34
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.